We’ve all heard about the TREAT Act and its effect on the availability of buprenorphine formulations like Suboxone. The TREAT Act, also known as Senate Bill 2645 or The Recovery Enhancement for Addiction Treatment Act, if passed, means that Suboxone, Subutex, and other forms of buprenorphine will be available for more people and waiting lists reduced. So what’s the holdup? The bill’s original ...